Results 181 to 190 of about 989 (256)

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

open access: yesEuropean Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak   +15 more
wiley   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis   +11 more
wiley   +1 more source

mPGES-1 deletion impairs diuretic response to acute water loading

open access: green, 2009
Sunhapas Soodvilai   +4 more
openalex   +2 more sources

Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS‐HF

open access: yesEuropean Journal of Heart Failure, EarlyView.
CV, cardiovascular, HF, heart failure; K+, serum potassium; eGFR, estimated glomerular filtration rate. Aims Finerenone improved heart failure (HF) outcomes in patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Clinical decision‐making around initiation of mineralocorticoid receptor antagonists often relies on
João Pedro Ferreira   +17 more
wiley   +1 more source

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

open access: yesEuropean Journal of Heart Failure, EarlyView.
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde   +24 more
wiley   +1 more source

Neutrophil‐to‐lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum

open access: yesEuropean Journal of Heart Failure, EarlyView.
Illustration defining the criteria for high‐risk acute myocarditis (AM), incorporating haemodynamic compromise, life‐threatening arrhythmias, and reduced left ventricular ejection fraction (LVEF <40%). Neutrophil‐to‐lymphocyte ratio (NLR) ≥4 is an independent risk marker, including among patients with preserved LVEF (≥50%) at presentation, where ...
Cristina Madaudo   +37 more
wiley   +1 more source

Chlorothiazide is associated with a weaker diuretic response than furosemide in infants with bronchopulmonary dysplasia (BPD) [PDF]

open access: gold
Timothy D. Nelin   +11 more
openalex   +1 more source

Artificial intelligence‐based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Artificial intelligence (AI)‐based estimation of stroke volume for risk prediction in amyloid transthyretin cardiomyopathy (ATTR‐CM). ATTRv, hereditary transthyretin amyloidosis; ATTRwt, wild‐type transthyretin amyloidosis; CI, confidence interval; HR, hazard ratio; IQR, interquartile range; LVOT‐VTI, left ventricular outflow tract velocity‐time ...
Lucia Venneri   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy